Pfizer Inc (NYSE:PFE) was incorporated in 1849 and specializes in prescription medicines for humans and animals around the globe. Based in New York, the company has two main business segments which are Biopharmaceutical segment and Diversified segment. The company’s products include Lipitor, Lyrica, Prevnar, Xalabrands, Effexor, Norvasc, Zyvox, Geodon, Zeldox, Detrol, Genotropin, Zoysyn, Genotropin, Protonix, Revatio, Pristiq, Spirvia, Caduet and Vfend.
Pfizer Inc (NYSE:PFE) is ranked 4th among its 169 competitor companies by dividend yield. The stock price is trading at a dividend yield of 4.30 percent as compared to highest dividend yield of 5.20 percent maintained in its industry. The company maintains the long term growth rate of 3.20 percent which ranks it 29th among its industry peers.
Pfizer Inc (NYSE:PFE) generated the total revenue of $16.98 billion for the quarter ended July 3rd, 2011 as compared to total revenue of $17.13 billion for the same period last year. The company reported the net profit of $2.61 billion or earnings of $0.33 per share for the respective quarter as compared to net income of $2.47 billion or earnings of $0.30 per share last year.
The company’s total assets accumulate up to $195.89 billion out of which current assets have the highest proportion. The company maintains a strong short term liquidity position as per its current ratio of 1.98 times.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.